Pitney Bowes Inc., operates as a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to small businesses, large enterprises, and government entities around the world. It operates through SendTech Solutions and Presort Services segments. The SendTech Solutions segment provides physical and digital shipping and mailing technology solutions, and other applications for sending, tracking and receiving of letters, parcels and flats, supplies, and maintenance services, as well as financing alternatives to finance equipment and product purchases. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, marketing mail flats, and bound printed matter for postal workshare discounts. It markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Pitney Bowes Inc.

Pitney Bowes ( ($PBI) ) has provided an announcement. On November 21, 2025, Pitney Bowes announced the commencement of cash tender offers to purcha...

Pitney Bowes Announces Cash Tender Offers for Notes

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals Limited announced the successful passing...

Paradigm Biopharmaceuticals’ AGM Resolutions Passed Successfully

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has issued a Cleansing Notice related to the i...

Paradigm Biopharmaceuticals Secures Additional Funding Through Convertible Notes

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals Limited announced the issuance of 5,000,...

Paradigm Biopharmaceuticals Issues 5 Million Convertible Notes

An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a US$5 million drawdown under ...

Paradigm Biopharmaceuticals Secures Funding for Global Clinical Expansion

POSaBIT Systems Corp (($TSE:PBIT)) has held its Q3 earnings call. Read on for the main highlights of the call. POSaBIT Systems Corp’s recent earnin...

POSaBIT’s Earnings Call: Profitability and Expansion Focus

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has shared an update. Paul Rennie, a significant shareholder in Paradigm Biopharmaceuticals, has ceased t...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PBI	$9.63	+2.56%	3.00M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PBI	$9.63	+2.6%	3.00M
3
4
5
6

PBI

PBI

Get Pitney Bowes Inc. Data in Excel

Get Pitney Bowes Inc. Data in Excel